Scarica l'app Stockscreener
102.71
3.70%
-3.95
Dopo l'orario di chiusura:
103.75
1.04
+1.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$106.66
Aprire:
$105.5
Volume 24 ore:
3.39M
Relative Volume:
1.52
Capitalizzazione di mercato:
$16.26B
Reddito:
$4.34B
Utile/perdita netta:
$-965.00M
Rapporto P/E:
-16.92
EPS:
-6.07
Flusso di cassa netto:
$869.00M
1 W Prestazione:
-4.58%
1M Prestazione:
+7.65%
6M Prestazione:
-22.62%
1 anno Prestazione:
-16.22%
Intervallo 1D:
$102.29
$107.63
Intervallo di 1 settimana:
$102.29
$111.00
Portata 52W:
$68.70
$156.66
Illumina Inc Stock (ILMN) Company Profile
Nome
Illumina Inc
Settore
Industria
Telefono
(858) 202-4500
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Confronta ILMN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
102.71 | 16.88B | 4.34B | -965.00M | 869.00M | -6.07 |
|
TMO
Thermo Fisher Scientific Inc
|
467.68 | 180.17B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.16 | 146.07B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
534.31 | 46.01B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.81 | 33.53B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
185.86 | 32.56B | 15.50B | 1.33B | 2.16B | 7.34 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-11 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Reiterato | Citigroup | Neutral |
| 2025-02-28 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-02-10 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-11-12 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-08-28 | Aggiornamento | Argus | Hold → Buy |
| 2024-08-16 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-01-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-11-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Iniziato | Bernstein | Underperform |
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-25 | Downgrade | Argus | Buy → Hold |
| 2023-01-05 | Iniziato | Scotiabank | Sector Perform |
| 2022-12-12 | Downgrade | Citigroup | Neutral → Sell |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-04 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Underweight |
| 2020-12-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-10-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Downgrade | Stifel | Buy → Hold |
| 2020-09-22 | Downgrade | UBS | Buy → Neutral |
| 2020-09-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-24 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-25 | Iniziato | Guggenheim | Buy |
Mostra tutto
Illumina Inc Borsa (ILMN) Ultime notizie
Illumina’s Q2 2025 Earnings and Strategic Moves - TipRanks
Illumina Q2 2025 slides: revenue declines 3% while margins expand, SomaLogic acquisition announced - Investing.com
Illumina: Q2 Earnings Snapshot - Norwalk Hour
Illumina Outpaces Wall Street Despite Sliding Revenue In Q2 - Finimize
Illumina Beats Profit Forecasts Even As Sales Slip Slightly - Finimize
When is Illumina Inc. stock expected to show significant growthMarket Forecast Opportunities Backed By Experts - jammulinksnews.com
Illumina: A 5.2 Rating Amid Challenges and Opportunities - The Globe and Mail
Earnings call transcript: Illumina beats Q2 2025 EPS forecast by 17.8% - Investing.com
Illumina Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Illumina (NASDAQ:ILMN) Surprises With Q2 Sales - TradingView
Illumina reports a decline in revenue despite beating estimates - Seeking Alpha
Illumina earnings beat by $0.18, revenue topped estimates - Investing.com Canada
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025 - PR Newswire
Biotech contractor settles for $9.8 million with DOJ over alleged cybersecurity lapses - The Record from Recorded Future News
Illumina, DOJ Reach $9.8 Million False Claims Act Settlement - Bloomberg Law News
Illumina agrees to $9.8 million settlement over cybersecurity vulnerabilities in genomic sequencing systems - MLex
Illumina Inc. Agrees to Pay $9.8M in Settlement Over Alleged Security - Hoodline
Illumina to Pay $9.8M to Resolve Cybersecurity Qui Tam Lawsuit Filed Under False Claims Act - USA Herald
What is the dividend policy of Illumina Inc. stockAdvanced Screener Guidance From AI Tools - jammulinksnews.com
Gear Up for Illumina (ILMN) Q2 Earnings: Wall Street Estimates for Key Metrics - sharewise.com
What are analysts’ price targets for Illumina Inc. in the next 12 monthsLow Risk Watchlist That Work - jammulinksnews.com
Illumina Releases TSO 500 v2 Assay with Integrated HRD Detection and Reduced Sample Requirements - geneonline.com
Illumina To Pay $9.8M To Resolve Cybersecurity Qui Tam Case - Law360
Veterinary scientists from 39 states gather to learn whole-genome sequencing - Illumina
Illumina enhances flagship cancer research assay with new features - Investing.com Australia
Illumina enhances flagship cancer research assay with new features By Investing.com - Investing.com South Africa
Illumina's New Cancer Test Breakthrough: Built-in HRD Detection Makes Tumor Profiling Faster and Easier - Stock Titan
Global Cancer Profiling Market Outlook to 2031: Growth Insights with Illumina, Qiagen, Thermo Fisher, and Roche - openPR.com
Illumina (ILMN) To Report Earnings Tomorrow: Here Is What To Expect - FinancialContent
DNA Sequencing Market Exclusive Report with Detailed Study - openPR.com
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm - ACCESS Newswire
What are Illumina Inc. company’s key revenue driversSmart Portfolio Recommendation For Beginners - jammulinksnews.com
Does Illumina Inc. stock perform well during market downturnsSwing Trade Outlook For Every Investor - jammulinksnews.com
Illumina (ILMN) Stock Is Up, What You Need To Know - Yahoo Finance
What is Illumina Inc. company’s growth strategyBreakout stock performance - jammulinksnews.com
How strong is Illumina Inc. company’s balance sheetTurbocharged investment results - jammulinksnews.com
What institutional investors are buying Illumina Inc. stockBuild wealth steadily with proven investment strategies - jammulinksnews.com
How many analysts rate Illumina Inc. as a “Buy”Free Predictions - jammulinksnews.com
What drives Illumina Inc. stock priceOutstanding stock performance - PrintWeekIndia
Illumina Inc. Stock Analysis and ForecastSky-high profits - PrintWeekIndia
U.S. Minimal Residual Disease Testing Market Trends Analysis Report 2025-2033 | Integration with Personalized Medicines, & Rising Incidence and Prevalence of Hematological Malignancies Fueling Growth - GlobeNewswire Inc.
Does Illumina Inc. stock pay reliable dividendsOutperformance with explosive growth - jammulinksnews.com
Is Illumina Inc. a good long term investmentStrongest growth potential - PrintWeekIndia
Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Microfluidic Market To Witness Substantial Growth, 2025-2032 | - openPR.com
(ILMN) Investment Analysis and Advice - news.stocktradersdaily.com
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
ILLUMINA, INC. (ILMN) - MSN
Whole Genome Sequencing Market Booming, to Reach US$ 8,608 - openPR.com
Multi-Omics Market Attracts Big Players, to Hit $33.25B by 2033 | - openPR.com
What analysts say about Illumina Inc. stockOutstanding growth strategies - Autocar Professional
Illumina Inc Azioni (ILMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):